empty
05.02.2025 12:44 AM
Pfizer Stock Rises: Why Now is the Best Time to Trade?

On Tuesday, shares of Pfizer Inc. rose by 1.7% in pre-market trading following the release of its Q4 2024 financial report, which exceeded analysts' expectations.

The American pharmaceutical giant reported a net profit of $410 million, or 7 cents per share. This represents a significant improvement compared to a loss of $3.37 billion, or 60 cents per share, during the same period last year.

The company's revenue increased by 22%, totaling $17.76 billion, compared to $14.57 billion in Q4 2023. This performance surpassed FactSet's consensus estimate of $17.35 billion.

This image is no longer relevant

This growth is primarily due to a one-time non-cash revenue return of $3.5 billion associated with its antiviral drug Paxlovid. Additionally, there has been an increase in sales from the Seagen oncology portfolio, the Vyndaqel family for cardiovascular treatment, and overall growth in Paxlovid sales.

Total sales of Paxlovid reached $727 million, a significant improvement compared to the $3.14 billion loss recorded last year, which stemmed from the transition to a traditional commercial sales model in the U.S.

Furthermore, Pfizer experienced a positive impact from currency fluctuations, which added an extra $62 million to its overall revenue. The company's management has reaffirmed its forecast for 2025, projecting revenue between $61 billion and $64 billion, with adjusted earnings per share ranging from $2.80 to $3.00.

According to FactSet, the average analyst expectations are for revenue of $63.07 billion and earnings of $2.91 per share.

Pfizer's CFO, David Denton, expressed confidence that the company will return to pre-pandemic operational margin levels in the coming years and achieve total cost savings of $4.5 billion by the end of 2025.

This situation presents several opportunities for traders. Pfizer's stock has risen following a strong earnings report, which may indicate a continuation of this upward trend, making the company's shares attractive for short- and medium-term speculative trades.

Furthermore, considering the company's long-term prospects in innovative drug development, Pfizer remains a promising asset for investors seeking stable capital growth.

Access to Pfizer shares and other leading global companies is available through the InstaForex trading platform.

Fast order execution, a wide range of instruments including CFDs on U.S. stocks, and no deposit restrictions enable traders to respond swiftly to market changes.

The availability of leverage up to 1:1000 and low commissions also provides additional opportunities for effective capital management.

Given the high volatility in the pharmaceutical sector and the upcoming release of key data on drug sales, investors should monitor Pfizer's stock closely.

In the upcoming quarters, the company is expected to continue growing its revenue by expanding its portfolio of prescription drugs, which could lead to further increases in its share prices.

Ekaterina Kiseleva,
Analytical expert of InstaForex
© 2007-2025
Select timeframe
5
min
15
min
30
min
1
hour
4
hours
1
day
1
week
Earn on cryptocurrency rate changes with InstaForex
Download MetaTrader 4 and open your first trade
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST

Recommended Stories

US Market News Digest for April 17

Jerome Powell's latest remarks triggered a sharp sell-off in US equities. Both the S&P 500 and the Nasdaq posted notable losses after the Fed chairman said that interest rates

Ekaterina Kiseleva 11:21 2025-04-17 UTC+2

When it all went wrong: Nvidia under pressure, stocks fall, Powell waits for clarity

Powell says economy slowing in Q1, may wait for more clarity European stocks slip ahead of ECB policy decision Nvidia warns of blame over US chip export restrictions to China

Thomas Frank 10:27 2025-04-17 UTC+2

US stock market in red zone: Dow Jones – 0.4%, Nasdaq – 0.1%. Upbeat corporate reports do not save Wall Street

The US stock market closed Tuesday with minor losses, as uncertainty over trade duties continued to weigh on investor sentiment. Consumer and healthcare stocks were particularly affected, though strong earnings

11:38 2025-04-16 UTC+2

US Market News Digest for April 16

Wall Street ended the session in the red. Shares of giants Boeing and Johnson & Johnson took the biggest hit as uncertainty around tariff policy continues to weigh on investor

Ekaterina Kiseleva 11:12 2025-04-16 UTC+2

Markets in the Red: Dow -0.4%, Nasdaq -0.1% as Strong Reports Fail to Save Wall Street

Bank of America Gains After Higher Q1 Earnings Uncertainty Over Tariff Outlook Still High Markets Ripple on U.S.-China Debate Indices: Dow Down 0.4%, S&P 500 Down 0.2%, Nasdaq Down 0.1%

Thomas Frank 07:54 2025-04-16 UTC+2

Apple soars. Stock investors alert to Netflix' report

US stocks are printing modest gains as tariffs on some electronic goods have been delayed. Tech stocks are outperforming European and Asian counterparts, with Apple shares jumping. Goldman Sachs

11:42 2025-04-15 UTC+2

US Market News Digest for April 15

The Trump administration has made concessions: tariffs on electronics have been temporarily lifted, and looser conditions for the auto industry are under consideration. These moves triggered a positive reaction —

Ekaterina Kiseleva 11:29 2025-04-15 UTC+2

Apple surges, market freezes in anticipation of Netflix: what's happening in the US stock market

US stocks show modest gains as tariffs on some electronics are delayed Tech stocks outperform European and Asian ones, Apple shares jump Goldman Sachs rises after results More earnings expected

Thomas Frank 09:50 2025-04-15 UTC+2

US Market News Digest for April 14

The US stock market rallied after President Donald Trump announced the removal of tariffs on computers and smartphones. The decision delivered a particularly strong boost to companies such as Apple

Ekaterina Kiseleva 12:09 2025-04-14 UTC+2

European chipmakers rejoice as US lifts stocks

A rally in tech stocks helped lift European shares on Monday after US President Donald Trump granted exemptions to Chinese tariffs on smartphones and computers, giving markets a break after

Thomas Frank 11:14 2025-04-14 UTC+2
Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.